Severe and sometimes fatal skin reactions have been reported in patients treated with Biogen lymphoma drug Zevalin, the U.S. Food and Drug Administration reported.
The reactions were reported in patients treated with the approved Zevalin regimen, which includes Rituxan.
From various sources, including Biogen's site.
